PR Newswire Asia's news > Biotechnology

 < Previous page   |   Detail   |   Print    Next page > 
     
Earendil Labs Announces First Patient Dosed in a Phase IIa Trial of a Half-life Extended Anti-TL1A Antibody (HXN-1001) in Patients with Ulcerative Colitis
2026-04-02T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
StairMed Secures RMB 500 Million Financing Led by Alibaba, Joined by Tencent
2026-04-02T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Caliway Selected to Present Preclinical Data on CBL-514 in Combination with GLP-1R Therapy at the American Diabetes Association's 2026 Scientific Sessions
2026-04-02T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Telix Appoints David Gill as Non-Executive Director
2026-04-02T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Bambusa Therapeutics Presented Positive Results from the Phase 1 Multiple Ascending Dose Trial of BBT001 at the 2026 American Academy of Dermatology (AAD) Annual Meeting
2026-04-01T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Sino Biological ProPure™ Endotoxin-Free Proteins: The "Invisible Guardian" of Biopharmaceuticals
2026-04-01T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Abbisko Therapeutics' FGFR4 Inhibitor Irpagratinib Granted Orphan Drug Designation by EMA for Hepatocellular Carcinoma
2026-04-01T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
NJ Bio, Inc. and Ajinomoto Bio‑Pharma Services Enter into Collaboration to Strengthen Support for Antibody-Drug Conjugate Development
2026-04-01T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Samsung Biologics completes acquisition of GSK's manufacturing facility in Rockville, Maryland
2026-03-31T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Co-PSMA data published in the European Urology journal
2026-03-31T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.